Ramiven 100mg (Abemaciclib) is a medication used to treat certain types of breast cancer, including:
- Hormone receptor-positive (HR+) and human epidermal growth factor receptor 2 (HER2)-negative breast cancer
- Hormone receptor-positive (HR+) and HER2-negative breast cancer that has progressed after treatment with other medications
Composition:
Abemaciclib is a cyclin-dependent kinase (CDK) inhibitor, which works by inhibiting the activity of CDKs. CDKs are proteins that help regulate cell growth and division.
Indications:
Ramiven 100mg (Abemaciclib) is indicated for the treatment of:
- Hormone receptor-positive (HR+) and HER2-negative advanced breast cancer in combination with fulvestrant
- Hormone receptor-positive (HR+) and HER2-negative advanced breast cancer in combination with letrozole
Dosage:
The recommended dosage of Ramiven 100mg is:
- 100 mg taken orally twice daily, with or without food
Side Effects:
Common side effects of Ramiven 100mg include:
- Fatigue
- Nausea
- Diarrhea
- Vomiting
- Abdominal pain
- Headache
- Muscle pain
- Joint pain
- Skin rash
- Hair loss
Contraindications:
Ramiven 100mg is contraindicated in patients who have:
- A history of severe allergic reactions to the medication
- Severe liver disease or liver failure
- Severe kidney disease or kidney failure
- Pregnant or breastfeeding women
- Patients with a history of QT prolongation or other conditions that can increase the risk of QT prolongation
Important Note:
Ramiven 100mg is a prescription medication and should only be used under the supervision of a qualified healthcare professional. Patients should be advised to monitor their blood counts and liver function regularly during treatment.
Reviews
There are no reviews yet.